Infrared Imaging for Breast Cancer Modeling

Status: complete

This study investigates the use of infrared (thermal) imaging of the breast in detecting breast cancer. Thermal imaging measures natural body heat, just like night vision goggles. It uses an “infrared camera,” which is just like a photo camera, but designed to measure infrared heat. Taking thermal (or infrared) images of patients referred for biopsy based on their diagnostic imaging results (e.g., mammograms or ultrasound), may help researchers build an advanced computational thermal model of the female breast with and without cancer. Learning more about thermal imaging of the breast, may eventually help researchers use thermal imaging to detect breast cancer early.

Inclusion Criteria

Referred for biopsy based on results of standard diagnostic breast exams
Ability to understand and the willingness to sign a written informed consent

Exclusion Criteria

Subjects who have started treatment and/or intervention for breast cancer, including biopsy, lumpectomy, or mastectomy
Chemotherapy, radiotherapy, or other cancer therapy within EVER weeks prior to starting study treatment. Subjects must have recovered from prior treatment-related to toxicities to grade 1 or baseline (excluding alopecia and clinically stable toxicities requiring ongoing medical management, such as hypothyroidism from prior immune checkpoint inhibitor treatment)
Subjects may not be receiving any other investigational agents for the treatment of the cancer under study
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that, in the opinion of the investigator, would limit compliance with study requirements

PRIMARY OBJECTIVE:

I. To obtain infrared (IR) images of breast cancer patients’ breasts (i.e., thermograms) under normal ambient conditions PRIOR TO intervention/treatment.

SECONDARY OBJECTIVES:

I. To obtain IR video of breast cancer patients’ malignant breast after cooling local biopsy region (e.g., with ice pack or cold wet wipe).

II. To repeat IR imaging procedure of patients’ breasts (i.e., thermograms) AFTER intervention/treatment (OPTIONAL).

III. To provide University of Texas at Dallas (UTD) researchers with (x,y,z) spatial location of the breast tumor from standard radiological imaging procedures (e.g., mammography, ultrasound, magnetic resonance imaging [MRI], etc.) for patients that ultimately diagnosed with breast cancer.

IV. To obtain 3 dimensional (D) surface contour geometry of breast cancer patients’ breasts via radiological imaging (e.g., MRI) or 3D scanning device (e.g., Polhemus FastSCAN II, Creaform GoSCAN3D or HandySCAN devices).

V. To construct a computational biothermal engineering model of the cancerous breast and use all data provided to validate the model.

OUTLINE:

Patients undergo IR imaging and 3D scan over 30-60 minutes.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.

Infrared Imaging for Breast Cancer Modeling

Description

Eligibility Criteria

Locations & Contacts

Trial Objectives and Outline

Trial Phase & Type

Lead Organization

Trial IDs

Have a question?We're here to help

Which trials are right for you?

Have a question?
We're here to help